Skye Bioscience: Funding, Investors & Team (Oct 2026)
Skye Bioscience is a biopharmaceutical company that specializes in identifying, creating, and selling new chemical substances known as cannabinoids. These compounds have a wide range of chemical properties and are intended to treat various diseases and symptoms by specifically targeting CB1 and CB2 receptors. Skye Bioscience aims to develop a unique and exclusive group of potential therapeutic products that can affect the nervous and immune systems without causing the unwanted side effects commonly seen in current medications.
Skye Bioscience has raised $17.0M across 1 funding round on record, the most recent an undisclosed round of $17.0M announced in Aug 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Skye Bioscience Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Skye Bioscience Funding Rounds
Skye Bioscience Founders and Leadership Team
No contact details are on record for this team yet.
Skye Bioscience Funding Compared to Other Biotechnology Startups
Skye Bioscience's latest round of $17.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Skye Bioscience in Biotechnology and San Diego
Companies Similar to Skye Bioscience
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Skye Bioscience Funding FAQs
What does Skye Bioscience do?
Skye Bioscience is a biopharmaceutical company that specializes in identifying, creating, and selling new chemical substances known as cannabinoids. These compounds have a wide range of chemical properties and are intended to treat various diseases and symptoms by specifically targeting CB1 and CB2 receptors. Skye Bioscience aims to develop a unique and exclusive group of potential therapeutic products that can affect the nervous and immune systems without causing the unwanted side effects commonly seen in current medications.
How much funding has Skye Bioscience raised?
Skye Bioscience has raised $17.0M across 1 round on record. The most recent is an undisclosed round of $17.0M announced in Aug 2023.
When did Skye Bioscience last raise funding?
Skye Bioscience's most recent funding round on record is an undisclosed round of $17.0M, announced in Aug 2023.
Who founded Skye Bioscience?
FundedIQ lists Cosmas Lykos (Founder) at Skye Bioscience.
Where is Skye Bioscience headquartered?
Skye Bioscience is based in San Diego, California, United States.
How many employees does Skye Bioscience have?
Skye Bioscience is in the 11-50 employee band.
How does Skye Bioscience's funding compare to other Biotechnology startups?
Skye Bioscience's latest round of $17.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Skye Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Skye Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.